Changes of the Infusion Rate in Insulin Pump Treatment

A pharmacokinetic study of insulin pump treatment using Insulin Aspart. The study consist of three different periods A, B and C where a constant the insulin infusion rate is given during the periods. Each period will last 12 hours and blood will be drawn to measure absorbed Insulin Aspart. During period A will a constant the infusion rate of insulin be given. In period B and C will there at the start of the constant infusion rate be given a bolus. The bolus in period C is calculated on the basis of the results in period B, therefore will all participants experience period C last where as period A and B is randomized cross-over. Period C is written in the protocol as optional and it is evaluated after period A and B if period C will be performed.

The hypothesis is that steady state of insulin will be obtained faster in period B and C than A.

Inclusion criteria

• Informed consent
• Healthy volunteer
• Men and women between ≥18 and <50 years
• Women in the child-bearing age should be sufficient protected against pregnancy (use birth control pill or intrauterine device or be sterilized or hysterectomized)
• BMI between 18-30 kg/m^2 (both included)

Exclusion criteria

• Suspected or known allergy against the drug used in the study or similar drugs
• Previous history of endocrinology disease (including Diabetes Mellitus)
• Suspected or known alcohol- or drug abuse
• Any disease influencing the study, evaluated by the investigator
• Pregnancy, breast-feeding or the wish of becoming pregnant during the study period. Furthermore women in the child bearing age not sufficient protected against pregnancy (sufficient is: use of birth control pill or intrauterine device or be sterilized or hysterectomized)
• Participation in other research projects during the last 3 months before this project